|
| 35012410 | Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. | J Asthma | 2023 |
| 37034358 | Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. | EClinicalMedicine | 2023 |
| 37033631 | Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study. | Front Pharmacol | 2023 |
| 36696128 | Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic. | JAMA Psychiatry | 2023 |
| 36935011 | Representing and utilizing clinical textual data for real world studies: An OHDSI approach. | J Biomed Inform | 2023 |
| 36692805 | Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study. | Drugs | 2023 |
| 36976448 | Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends. | Drug Saf | 2023 |
| 35012410 | Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. | J Asthma | 2023 |
| 36976448 | Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends. | Drug Saf | 2023 |
| 37034358 | Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. | EClinicalMedicine | 2023 |
| 37033631 | Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study. | Front Pharmacol | 2023 |
| 36696128 | Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic. | JAMA Psychiatry | 2023 |
| 36692805 | Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study. | Drugs | 2023 |
| 36935011 | Representing and utilizing clinical textual data for real world studies: An OHDSI approach. | J Biomed Inform | 2023 |
| 35323951 | Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort. | JAMA Netw Open | 2022 |
| 35691322 | Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. | Lancet | 2022 |
| 35865358 | Recommendations for achieving interoperable and shareable medical data in the USA. | Commun Med (Lond) | 2022 |
| 36188566 | International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients. | Front Pharmacol | 2022 |
| 35094685 | Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. | BMC Med Res Methodol | 2022 |
| 35345821 | Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS. | Clin Epidemiol | 2022 |
| 35323951 | Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort. | JAMA Netw Open | 2022 |
| 35345821 | Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS. | Clin Epidemiol | 2022 |
| 35691322 | Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. | Lancet | 2022 |
| 35865358 | Recommendations for achieving interoperable and shareable medical data in the USA. | Commun Med (Lond) | 2022 |
| 36188566 | International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients. | Front Pharmacol | 2022 |
| 35094685 | Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. | BMC Med Res Methodol | 2022 |
| 33411620 | Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. | JCO Clin Cancer Inform | 2021 |
| 33688639 | Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. | Res Sq | 2021 |
| 33791740 | Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study. | medRxiv | 2021 |
| 34272262 | Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34049958 | Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience. | Pediatrics | 2021 |
| 34267326 | Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. | Int J Obes (Lond) | 2021 |
| 33775125 | Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study. | Hypertension | 2021 |
| 33725121 | COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. | Rheumatology (Oxford) | 2021 |
| 33611874 | Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary. | Healthc Inform Res | 2021 |
| 33936474 | Characterizing database granularity using SNOMED-CT hierarchy. | AMIA Annu Symp Proc | 2021 |
| 33661754 | Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study. | JMIR Med Inform | 2021 |
| 34304580 | Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. | Hypertension | 2021 |
| 33975825 | Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. | BMJ | 2021 |
| 33367863 | Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. | Rheumatology (Oxford) | 2021 |
| 33269356 | Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States. | medRxiv | 2021 |
| 33411620 | Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. | JCO Clin Cancer Inform | 2021 |
| 34545824 | The Usage of OHDSI OMOP - A Scoping Review. | Stud Health Technol Inform | 2021 |
| 34937726 | Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. | BMJ Open | 2021 |
| 34930903 | Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. | Transl Psychiatry | 2021 |
| 33791740 | Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study. | medRxiv | 2021 |
| 33611874 | Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary. | Healthc Inform Res | 2021 |
| 33725121 | COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. | Rheumatology (Oxford) | 2021 |
| 33661754 | Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study. | JMIR Med Inform | 2021 |
| 33775125 | Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study. | Hypertension | 2021 |